Evaluation of the serologic response against two consensus V3 loop peptides from human immunodeficiency virus-1 in Cuban patients (Q45753574)

15 December 2017

title

Evaluation of the serologic response against two consensus V3 loop peptides from human immunodeficiency virus-1 in Cuban patients (English)

1 reference

15 December 2017

author name string

J Miguez

1

1 reference

15 December 2017

J Laferté

2

1 reference

15 December 2017

Y Tejero

3

1 reference

15 December 2017

G González

4

1 reference

15 December 2017

A J Otero

5

1 reference

15 December 2017

J Rivero

6

1 reference

15 December 2017

C Duarte

7

1 reference

15 December 2017

publication date

1 April 1998

1 reference

15 December 2017

International Journal of Infectious Diseases

published in

1 reference

15 December 2017

volume

2

1 reference

15 December 2017

issue

4

1 reference

15 December 2017

page(s)

221-225

1 reference

15 December 2017

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Analyses of functional antibody responses in HIV-1-infected individuals after vaccination with rgp160.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Antibodies of HIV-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (V3) of gp120

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

The measurement of relative antibody affinity by ELISA using thiocyanate elution

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Estimation of rotavirus immunoglobulin G antibodies in human serum samples by enzyme-linked immunosorbent assay: expression of results as units derived from a standard curve

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Predominance of HIV-1 serotype distinct from LAV-1/HTLV-IIIB.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

High antigenic cross-reactivity of the V3 consensus sequences of HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Determination of the affinity of antibodies to hepatitis B surface antigen in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Antibody affinity measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Measurement of affinity of viral monoclonal antibodies by ELISA titration of free antibody in equilibrium mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Restriction of serum antibody reactivity to the V3 neutralizing domain of HIV gp120 with progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Lack of isolate-specific neutralizing activity is correlated with an increased viral burden in rapidly progressing HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Loss of antibody reactivity directed against the V3 domain of certain human immunodeficiency virus type 1 variants during disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

Human Immunodeficiency Virus (HIV) Type 1 Strain MN Neutralizing Antibody in HIV-Infected Children: Correlation with Clinical Status and Prognostic Value

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2898%2990057-1

7 January 2021

10.1016/S1201-9712(98)90057-1

Identifiers

DOI

1 reference

15 December 2017

release_6ruockhwmvdi5bv4obai73zjv4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6ruockhwmvdi5bv4obai73zjv4

24 November 2022

mapped directly with Wikidata item

1 reference

15 December 2017